Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Achillion Pharmaceuticals, Inc.
(NQ:
ACHN
)
7.740
USD
-0.010 (-0.13%)
Official Closing Price
/ Updated:
4:30 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Achillion Pharmaceuticals, Inc.
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Achillion Reports Second Quarter and Six Month 2011 Financial Results
August 08, 2011
from
GlobeNewswire News Releases
Achillion to Host Conference Call to Discuss Second Quarter Financial Results and Upcoming Milestones
August 02, 2011
Conference Call Scheduled for 10:30 a.m. EDT on Tuesday, August 9, 2011
Read More
from
GlobeNewswire News Releases
Notable Analyst Rating Changes 07/26: (FNSR) (S) (SOHU) Upgraded; (STEC) (NVDA) (GNK) Downgraded
July 26, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6659810 for the full story.
Read More
from
StreetInsider.com News Articles
Wedbush Assumes Achillion Pharmaceuticals (ACHN) at Outperform; Diverse and Differentiated Pipeline
July 26, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6658670 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Announces Executive Promotion
July 26, 2011
from
GlobeNewswire News Releases
Long-Term Positives En-Route, Review of Healthcare Reform - Equity Research on Achillion Pharmaceuticals, Inc. and Health Management Associates, Inc.
July 22, 2011
from
Marketwired News Releases
Achillion (ACHN) Initiates HCV Treatment Phase 1
July 11, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6629575 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) Begins Phase 1 Clinical Trial of ACH-2928
July 11, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6629574 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Announces Initiation of Phase 1 Trial of ACH-2928 for the Treatment of Hepatitis C
July 11, 2011
First-in-Human Trial to Evaluate Safety and Tolerability of First Generation NS5A Inhibitor in Both Healthy Subjects and Genotype 1 HCV-Infected Patients
Read More
from
GlobeNewswire News Releases
Unusual 11 Mid-Day Movers 07/07: (CALI) (APAC) (ACHN) Higher; (LL) (AFFX) (IDRA) Lower
July 07, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6625823 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion (ACHN) Talking with Peers on Possible Partnerships, Sale -DealReporter
June 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6606731 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharma (ACHN) Shares Jump in Afternoon Trade, Now Up Almost 16%
June 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6606668 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharma (ACHN) Closes 10M Common Offering; Over-Allotment Exercised
June 27, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6604348 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharmaceuticals Announces Closing of Public Offering and Exercise of Overallotment Option
June 27, 2011
from
GlobeNewswire News Releases
Achillion Pharmaceuticals (ACHN) NewsBite - ACHN Falls 1.9% on Profit-Taking
June 23, 2011
Achillion Pharmaceuticals (NASDAQ: ACHN) opened at $7.10. So far today, the stock has hit a low of $7.06 and a high of $7.34. ACHN is now trading at $7.12, down $0.14 (-1.93%)....(Click the story link...
Read More
category
ACHN
from
MarketIntelligenceCenter.com
ACHN, AVAV, WNR, ZAGG Among Charts to Watch
June 23, 2011
The market was doing well on Wednesday until Fed’s Bernanke spoke. The market then dropped sharply in the last hour and a half, and a lot of the gains were cut back or dissipated. We’re going to...
Read More
from
Charts of the Day by Harry Boxer
Achillion Pharmaceuticals Leads MicroStockProfit.com Stock Watchlist
June 23, 2011
from
GlobeNewswire News Releases
Wednesday's HealthCare Sector Gainers (ACHN, LMNX, GERN) & Losers (NUVA, INHX, SNMX) by Stockmister.com
June 23, 2011
from
EmailWire.Com Press Releases
Achillion Prices Offering
June 22, 2011
Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) priced its public offering of 9.6 million common shares at $5.90 per share to raise approximately $52.9 million. The stock price leaped $1.25 to close at...
Read More
from
MarketMinute.com Stock News
Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C
June 22, 2011
from
GlobeNewswire News Releases
Unusual 11 Mid-Day Movers 06/22: (ACHN) (AVAV) (AERL) Higher; (FSII) (PHG) (LZB) Lower
June 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6597260 for the full story.
Read More
from
StreetInsider.com News Articles
Drug stocks mixed after Fed statement
June 22, 2011
Drug stocks are mixed after the Federal Reserve announces it is keeping its lending rate at an all-time low and is ending the controversial bond-buying program dubbed QE2.
Read More
category
Biotechnology
,
Retail
,
Financial Services
, and 18 more.
from
MarketWatch
Morning Movers 06/22: (AVAV) (SOL) (SPAR) (HSOL) Higher; (FSII) (PHG) (LZB) Lower
June 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6596815 for the full story.
Read More
from
StreetInsider.com News Articles
Lower Open Ahead Of Rate Decision
June 22, 2011
The markets opened lower with the Dow losing 15 points to 12,174 ahead of the Federal Reserve's interest rate decision. Nasdaq slipped 3 points to 2684.
Read More
category
Market News
from
MarketMinute.com Market Updates
Achillion Pharma (ACHN) prices 9.6M shares at $5.90/share
June 22, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6596095 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock
June 22, 2011
from
GlobeNewswire News Releases
Pre-Open Movers 6/21: (TOBC) (BBY) (MDR) Higher; (WAG) (ESRX) (PSEC) Lower (more...)
June 21, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6593770 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) Announces 9 Million Share Public Offering
June 20, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6591898 for the full story.
Read More
from
StreetInsider.com News Articles
Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock
June 20, 2011
from
GlobeNewswire News Releases
May's Healthcare Winners (ACHN, SCLN, TRNX, GTXI, ALKS)
June 02, 2011
Check out May's Best Performing Healthcare Stocks!
Read More
from
Investopedia Advisor Commentary
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here